EUR m | 12M 2023 | 12M 2022 |
Revenue | 1,914.3 | 1,771.9 |
EBITDA (adjusted) | 568.8 | 541.4 |
Exceptional items | -14.6 | 0.8 |
EBITDA | 554.2 | 542.2 |
Amortization, depreciation and impairment | -323.4 | -303.5 |
thereof attributable to purchase price allocations and impairment losses | -20.9 | -27.3 |
EBIT | 230.8 | 238.7 |
Net finance income/costs | -65.8 | -27.9 |
EBT | 165.0 | 210.8 |
Taxes | -52.6 | -59.0 |
Consolidated profit or loss for the period | 112.4 | 151.8 |
Adjusted consolidated profit or loss for the period | 143.0 | 171.5 |
Free cash flow (before M&A transactions) | 271.9 | 248.3 |
Net debt ( 31 Dec) | 770.0 | 718.0 |
In EUR m | Q1 2024 | Q1 2023 |
Revenue | 453.4 | 409.9 |
EBITDA (adjusted) | 108.4 | 97.2 |
Exceptional items | -4.7 | -2.8 |
EBITDA | 103.8 | 94.4 |
Amortization, depreciation and impairment | -76.9 | -76.0 |
thereof attributable to purchase price allocations and impairment losses | -3.2 | -4.9 |
EBIT | 26.9 | 18.3 |
Net finance income/costs | -18.3 | -13.6 |
EBT | 8.6 | 4.7 |
Taxes | -2.6 | -1.3 |
Consolidated profit or loss for the period | 6.0 | 3.4 |
Adjusted consolidated profit or loss for the period | 12.5 | 8.9 |
Free cash flow (before M&A transactions) | 24.6 | 21.2 |
Free cash flow (before M&A transactions)(Adjusted) | -24.4 | -14.5 |
Net debt (Mar. 31/Dec. 31) | 782.8 | 770.0 |